Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$9.21
52W Range
$2.14 - $12.90
50D Avg
$9.40
200D Avg
$5.67
Market Cap
$171.50M
Avg Vol (3M)
$94.05K
Beta
-0.14
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.